Tag Archives: licensing

Chinese In-Licensing Continues to Strengthen

Chinese companies are eager to collaborate with their ex-China counterparts, and in-licensing agreements are outpacing other forms of biotech deal-making in 2013. In fact, the number of in-licensing deals announced so far this year is more than the combined number of 2012 deals in out-licensing, JV/Alliance and M&A, according to BIO’s Industry Analysis research and GBI. This deal-making momentum bodes well for small and medium-sized biotech companies that have early-stage compounds under development in the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Preview: AUTM U.S. Licensing Survey: FY2011

044-btn

We’ve seen compelling evidence recently about the positive impact of university licensing activity. As we learned from “The Economic Contributions of University/Nonprofit Inventions in the United States: 1996-2010,” a report released by BIO in June, university/nonprofit licensing supported as many as 3 million “person years of employment.” Now there is even more good news to share. AUTM publishes a report of academic licensing activity at the end of each year for the prior fiscal year. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

AUTM Website Helps Commercialize University Technologies

Robin Rasor

By Robin L. Rasor, CLP, RTTP, AUTM President As president of the Association of University Technology Managers (AUTM), I’m in a unique position of hearing from university technology managers who want more opportunity to interact with industry, and industry members who want to identify the latest breakthrough innovations. Industry investors and their academic licensing counterparts already come together for dealmaking at the AUTM Annual Meeting and at the BIO International Convention, but now we have Read More >

Patently BIOtech  |  3 Comments  |  Email This Post
Tags: , , , , , ,

NIH Licensing Efforts Target Start-Ups

NIH_Logo

The National Institutes of Health (NIH) has developed a new short-term licensing arrangement they hope will encourage licensing of NIH and FDA inventions to start-up companies.  The NIH Start-Up Exclusive License Agreements targets start-up companies less than 5 years old, with less than $5M in raised capital, and fewer thans than 50 employees.  By offering an exclusive license, they hope to accelerate the technology transfer process.  However, this temporary pilot program runs only until September 30, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Exclusive Licenses Do Not Discourage Follow On Research

medical_research_thumb

A recent study presented at the Patent Statistics for Decision Makers Conference organized at the United States Patent Office questions the logic behind a nonexclusive license preference often found in U.S. government technology transfer policy. In “The Role of Exclusive Licensing in Follow-on Research of Academic Patented Inventions” presentation the authors demonstrate that, contrary to the belief by some, exclusive licensing does not impede future research. The authors ask two questions.  First, does exclusive licensing affect licensee follow-on research?  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,